A Phase I Study of Photodynamic Therapy (PDT) Using 2-(1-Hexyloxyethyl)-2 Devinyl Pyropheophorbide-a (HPPH) for Treatment of Early Stage Lung Cancer - A Dose Ranging Study
Latest Information Update: 18 Sep 2021
At a glance
- Drugs HPPH (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- 07 Mar 2011 Biomarkers information updated
- 19 Sep 2005 New trial record.